Suture Anchor Devices Market Summary

The global suture anchor devices market was valued at USD 815.6 million in 2024 and is projected to reach USD 1,003.4 million by 2030, growing at a compound annual growth rate (CAGR) of 3.7% from 2025 to 2030. The market expansion is primarily driven by the increasing prevalence of sports-related injuries, which has led to a higher demand for effective suture anchor devices for repairing torn ligaments and tendons. Additionally, advancements in surgical techniques and improvements in the materials used in these devices have significantly enhanced their adoption across orthopedic procedures.

The rising global aging population, combined with the increasing incidence of orthopedic disorders such as rotator cuff injuries, shoulder dislocations, and joint instability, is further supporting market growth. Elderly patients are particularly prone to musculoskeletal injuries, and the use of suture anchor devices provides improved surgical outcomes, faster recovery, and better post-operative stability. The growing focus on minimally invasive surgical procedures and the integration of bioabsorbable and high-strength materials in suture anchors have also contributed to their widespread clinical acceptance.

Key Market Trends & Insights

• North America dominated the global suture anchor devices market in 2024, holding the largest revenue share of 41.0%. The region’s leadership is attributed to the well-established healthcare infrastructure, high awareness of advanced orthopedic treatments, and the presence of key market players.
• In contrast, the Asia Pacific region is projected to register the fastest growth during the forecast period, with a CAGR of 4.6%, driven by expanding healthcare access, increasing orthopedic procedures, and rising sports participation in countries such as China, India, and Japan.
• By product type, non-absorbable suture anchor devices led the market in 2024 with the largest revenue share of 55.1%, owing to their superior mechanical strength and long-term durability in tissue fixation. In terms of tying type, the knotless segment dominated the market, as knotless anchors simplify surgical procedures, reduce operative time, and enhance post-operative outcomes.
• By end-use, hospitals accounted for the largest revenue share in 2024, as they remain the primary setting for orthopedic surgeries, including rotator cuff repairs and ligament reconstructions.

Order a free sample PDF of the Suture Anchor Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 815.6 Million
• 2030 Projected Market Size: USD 1,003.4 Million
• CAGR (2025-2030): 3.7%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

Some of the dominant players operating in the market for suture anchor devices include Smith & Nephew plc; Zimmer Biomet Holdings Inc.; CONMED Corporation; Arthrex, Inc.; Johnson and Johnson (DePuy Synthes, Inc.); Stryker Corporation; Wright Medical; and OrthoMed.

• Smith & Nephew plc is a global medical product company specializing in orthopedic reconstruction, sports medicine, and wound management. It is recognized for its extensive array of orthopedic products, including advanced joint replacement systems, which have augmented its footprint in both emerging and established markets. Their sports medicine division, which emphasizes minimally invasive surgical solutions, drives significant growth in arthroscopic procedures, especially for tendon and ligament repairs.
• Zimmer Biomet Holdings Inc. offers innovative musculoskeletal healthcare solutions, offering a broad spectrum of products and services in orthopedics, spine, dental implants, and more. The company’s concentration on personalized care and advancements in robotics and 3D printing technologies for joint replacements contribute considerable value to its product offerings. Their emphasis on enhancing surgical solutions, particularly regarding patient-specific products such as custom implants, facilitates better surgical outcomes and quicker recovery periods.
• CONMED Corporation operates in over 80 countries worldwide. The company focuses on minimally invasive surgical devices and equipment for arthroscopy, providing solutions for orthopedic surgeries and sports medicine. This focus has resulted in the creation of state-of-the-art minimally invasive surgical instruments, improving accuracy and reducing patient recovery periods. The firm’s commitment to delivering superior arthroscopic equipment has established it as a reliable collaborator for orthopedic surgeons across the globe.

Meanwhile, Parcus Medical and Enovis Corporation are some of the emerging players operating in the suture anchor device market.

• Parcus Medical is a medical device company that offers over 400 innovative products in more than 60 countries worldwide, with a direct selling presence in countries outside the U.S. Their global presence, coupled with an emphasis on innovation and surgical solutions, places them in a strong position for sustained growth in the competitive medical device industry.
• Enovis Corporation is a medical device company specializing in developing orthopedic implants and instruments for spine surgery. It has positioned itself as a prominent entity in designing and developing these implants and instruments. Enovis Corporation focuses on improving surgical outcomes and patient recovery durations.

Key Players

• Smith & Nephew, plc.
• Zimmer Biomet Holdings, Inc.
• CONMED Corporation
• Arthrex, Inc.
• Johnson & Johnson Services, Inc. (DePuy Synthes, Inc.)
• Stryker (Wright Medical Group, Inc.)
• Parcus Medical, LLC (Medacta International)
• OrthoMed, Inc.
• Enovis Corporation
• Medtronic

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global suture anchor devices market is expected to grow steadily, driven by the rising prevalence of sports injuries, an aging population, and increasing demand for advanced orthopedic procedures. Innovations in device materials, surgical techniques, and minimally invasive procedures are enhancing clinical outcomes and expanding market adoption. North America currently leads the market, while Asia Pacific is emerging as the fastest-growing region due to rising healthcare accessibility and orthopedic awareness. Hospitals remain the primary end-users, reflecting the concentrated nature of orthopedic surgeries. Overall, sustained advancements, growing patient populations, and increasing focus on sports and orthopedic healthcare will continue to fuel market growth globally.